After a single administration of the antiepileptic drug valproic acid (VPA; i.p.: 600 mg/kg) on day 8 of gestation in the mouse embryotoxicity and amniotic fluid (AF) cholinesterase (ChE) were evaluated on day 16 of gestation. VPA treatment induced an increase in embryolethality, neural tube defects (exencephaly), cleft palate, deformed vertebrae, open eyes, and a reduction in fetal weight. In VPA-exposed fetuses AF total ChE (TChE) activity of exencephalic fetuses was higher than that of normal fetuses. However, in 3 out of 110 normal fetuses of the control group TChE activity was found in the AF. There was no correlation between blood contamination of AF and its TChE activity, either in non-exencephalic control or treated embryos. Using ethopropazine as a “pseudo”-ChE inhibitor in vitro, the percentage of acetyl-ChE in blood-contaminated AF was similar to that of fetal rather than maternal serum, indicating that AF was contaminated with fetal and not with maternal blood. VPA-induced exencephaly in mice may provide an animal model to further investigate biochemical markers for prenatal diagnosis of neural tube defects.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Brock DJH (1977) A review — prenatal diagnosis of neural tube defects. Eur J Clin Invest 7: 465–472
Christensen RL, Rea MR, Kessler G, Crane JP, Valdes R Jr (1986) Implementation of a screening program for diagnosing open neural tube defects: selection, evaluation, and utilization of alpha-fetoprotein methodology. Clin Chem 32 (10): 1812–1817
Chubb IW, Pilwsky PM, Springell HJ, Pollard AC (1979) Acetylcholinesterase in human amniotic fluid: an index of fetal neural development. Lancet I: 688–690
Cole KJ, Seller MJ (1982) Gel electrophoresis of maternal and fetal serum cholinesterases from normal pregnancies and of those affected by neural tube defects. Clin Chim Acta 119: 1–6
Collaborative Acetylcholinesterase Study (1981) Amniotic fluid acetylcholinesterase electrophoresis as a secondary test in the diagnosis of anencephaly and open spina bifida in early pregnancy. Lancet II: 321–324
Coombes EJ, Wood PJ, Spencer K, Batstone GF (1982) Improved discrimination in the detection of neural tube defects: five biochemical tests compared. Clin Chim Acta 122: 249–259
Dale G, Archibald A, Bonham JR (1981) Diagnosis of neural tube defects by estimation of amniotic fluid acetylcholinesterase. Br J Obstet Gynaecol 88: 120–125
Elejalde BR, Peck G, Elejalde MM (1986) Determination of cho- linesterase and acetylcholinesterase in amniotic fluid, uses in prenatal diagnosis and quality control. Clin Genet 29: 196–203
Ellmann GL, Courtney KD, Andrea V, Featherstone RM (1961) A new rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88–95
Jones SR, Evans SE (1983) A cholinesterase isoenzyme of fetal origin: A potential diagnostic marker. Lancet I: 412
Lee JES, Ng WG, Falk RE, Alfi O, Lopez L, Platt LD (1985) False-positive amniotic fluid acetylcholinesterase results. The need for a multifacet approach to the prenatal diagnosis of neural tube defects. Obstet Gynecol 66 (3): 22S-24S
Lorke D (1965) Embryotoxische Wirkungen an der Ratte. Naunyn Schmiedebergs. Arch Exp Pathol Pharmakol 250: 360–382
Nau H (1985) Teratogenic valproic acid concentrations: infusion by implanted minipumps vs conventional injection regimen in the mouse. Toxicol Appl Pharmacol 68: 243–250
Nau H (1986) Transfer of valproic acid and its main active unsat- urated metabolite to the gestational tissue: correlation with neural tube defect formation in the mouse. Teratology 33: 21–27
Nau H, Spielmann H (1983) Embryotoxicity testing of valproic acid. Lancet I: 763–764
Nau H, Zierer R, Spielmann H, Neubert D, Gansau C (1981) A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations. Life Sci 29: 2803–2814
Smith AD, Wald NJ, Cuckle HS, Stiratt GM, Bobrow M, Lager-crantz H (1979) Amniotic-fluid acetylcholinesterase as a pos- sible diagnostic test for neural-tube defects in early pregnancy. Lancet I: 685–688
UK Collaborative study on alphafetoprotein in relation to neural tube defects (1979) Amniotic fluid alphafetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. IInd report. Lancet II: 651–662
About this article
Cite this article
Elmazar, M.M.A., Vogel, R. & Spielmann, H. Amniotic fluid cholinesterase of valproate-induced exencephaly in the mouse: an animal model for prenatal diagnosis of neural tube defects. Arch Toxicol 61, 501–503 (1988). https://doi.org/10.1007/BF00293698
- Amniotic fluid
- Neural tube defects
- Prenatal diagnosis
- Valproic acid